V. Giau

发表

Recent advances in the treatment of C. difficile using biotherapeutic agents

S. An, Hyon Lee, John Hulme, 2019, Infection and drug resistance.

Development and Evaluation of a Multiplex PCR for Simultaneous Detection of Five Foodborne Pathogens

T. Nguyen, Vo Van Giau, Tuong Kha Vo, 2016 .

Genetic Factors of Cerebral Small Vessel Disease and Their Potential Clinical Outcome

S. An, Y. Youn, Eva Bagyinszky, 2019, International journal of molecular sciences.

Clinical genetic strategies for early onset neurodegenerative diseases

SangYun Kim, S. An, Eva Bagyinszky, 2018, Molecular & Cellular Toxicology.

Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease

T. Nguyen, Q. T. H. Ta, T. Nguyen, 2020, International journal of molecular sciences.

Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing

YoungSoon Yang, S. An, Y. Youn, 2019, Scientific Reports.

Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer’s Disease

S. An, S. Wu, Sang Yun Kim, 2018, Nutrients.

Novel PSEN1 p.Gly417Ala mutation in a Korean patient with early-onset Alzheimer's disease with parkinsonism

S. An, Y. Youn, Eva Bagyinszky, 2018, Neurobiology of Aging.

Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer’s disease

S. An, Eva Bagyinszky, C. Limwongse, 2018, Neuropsychiatric disease and treatment.

Role of apolipoprotein E in neurodegenerative diseases

S. An, Eva Bagyinszky, Vo Van Giau, 2015, Neuropsychiatric disease and treatment.

Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease

S. An, V. Giau, 2016, Journal of the Neurological Sciences.

Transcriptomics in Alzheimer’s Disease: Aspects and Challenges

Eva Bagyinszky, Vo Van Giau, SeongSoo A. An, 2020, International journal of molecular sciences.

A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer’s disease

S. An, Eva Bagyinszky, Jung-Min Pyun, 2018, Clinical interventions in aging.

A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer’s disease

SangYun Kim, S. An, Eva Bagyinszky, 2018, Clinical interventions in aging.

Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis

K. Suk, SangYun Kim, S. An, 2017, Journal of the Neurological Sciences.

Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases

Eva Bagyinszky, Youngmin Youn, Sangyun Kim, 2018, Neuropsychiatric disease and treatment.

Novel prion mutation (p.Tyr225Cys) in a Korean patient with atypical Creutzfeldt–Jakob disease

YoungSoon Yang, S. An, Y. Youn, 2019, Clinical interventions in aging.

Early-onset Alzheimer’s disease patient with prion (PRNP) p.Val180Ile mutation

Min Ju Kang, S. An, Eva Bagyinszky, 2019, Neuropsychiatric disease and treatment.

Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment

S. An, Eva Bagyinszky, V. Giau, 2019, International journal of molecular sciences.

Analysis of 50 Neurodegenerative Genes in Clinically Diagnosed Early-Onset Alzheimer’s Disease

S. An, Eva Bagyinszky, V. Senanarong, 2019, International journal of molecular sciences.

Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease

S. An, Eva Bagyinszky, Hyon Lee, 2018, Clinical interventions in aging.

Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.

Young Ho Park, Jae-Won Jang, S. An, 2016, Journal of Alzheimer's disease : JAD.

Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure

YoungSoon Yang, S. An, Sangyun Kim, 2018, Dementia and neurocognitive disorders.

Pathogenic PSEN1 Glu184Gly Mutation in a Family from Thailand with Probable Autosomal Dominant Early Onset Alzheimer’s Disease

S. An, Eva Bagyinszky, C. Limwongse, 2020, Diagnostics.

Novel GRN mutations in Koreans with Alzheimer’s disease

S. An, S. Choi, Eva Bagyinszky, 2019, Molecular & Cellular Toxicology.

APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease

S. An, Y. Youn, Eva Bagyinszky, 2019, International journal of molecular sciences.

Identification of a novel PSEN1 mutation (Leu232Pro) in a Korean patient with early-onset Alzheimer's disease and a family history of dementia

S. An, Y. Youn, Eva Bagyinszky, 2017, Neurobiology of Aging.

Current advances in transdermal delivery of drugs for Alzheimer's disease

T. Nguyen, Tuong Kha Vo, V. Giau, 2017, Indian journal of pharmacology.

Gene panels and primers for next generation sequencing studies on neurodegenerative disorders

S. An, Eva Bagyinszky, Sangyun Kim, 2015, Molecular & Cellular Toxicology.

Dynamic changes of protein corona compositions on the surface of zinc oxide nanoparticle in cell culture media

S. Son, Yoon-Hee Park, Kyuhwan Shim, 2019, Frontiers of Chemical Science and Engineering.

Clinical genetic strategies for early onset neurodegenerative diseases

S. An, Eva Bagyinszky, Sangyun Kim, 2018, Molecular & Cellular Toxicology.

Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing

YoungSoon Yang, S. An, Y. Youn, 2019, Scientific Reports.

Apolipoprotein ε7 allele in memory complaints: insights through protein structure prediction

S. An, Mi-Kyung Lee, Su-Hyun Han, 2017, Journal of the Neurological Sciences.

Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease

S. An, V. Giau, 2016, Journal of the Neurological Sciences.

Current advances in transdermal delivery of drugs for Alzheimer's disease

Tuong Kha Vo, V. Giau, T. Nguyen, 2017, Indian journal of pharmacology.